drugmanrx
11 minutes ago
"On January 30, 2023, the Company entered a letter of intent to acquire Prodigy Stem Cell, LLC (“Prodigy”), with an effective acquisition date of March 1, 2023, in consideration of $50,000 and the issuance of 1,000,000 shares of Series B Preferred Stock to Prodigy’s sole member, Peter Caruso. On Mar